In a first, the Human Immunodeficiency Virus (HIV) has been isolated and processed to treat patients infected with HIV through applied use of homoeopathic science. The research paper, after undergoing clinical trials for its safety and efficacy in Mumbai, was published in the Indian Journal of Research in Homeopathy (IJRH) on March 31. While the medicine, called ‘Nosode’, does not entirely cure HIV patients, the successful trial opens up possibilities of future research in homoeopathy.
HIV infection affects the body immune system and makes the patient prone to other diseases. It may cause death in several cases.
During the four-year-long study conducted in the city, 27 Mumbai-based HIV positive patients were administered Nosode, of which 52 per cent showed stability or improvement in the CD-4 count in the body. CD-4, also called ‘fighter cells’, are white blood cells that combat infection. If the CD-4 count falls below 350, a person suffers from Acquired Immunodeficiency Syndrome (AIDS) and has to be put on Anti-retroviral Treatment (ART).
Research suggests hope for homoeopathic vaccine to treat malaria HIV cases dip, transmission through unprotected sex still high in Mumbai Scientists identify new, more effective way to treat HIV NACO modifies treatment guidelines in AIDS control programme South African girl becomes third child with HIV in remission, says study New AIDS approach disrupts patient's DNA
According to the city-based author of the study, Dr Rajesh Shah, of the total patients in the trial, 63 per cent showed an improvement in appetite. “The homoeopathic medicine helped in improving weight, appetite and we noticed a fall in the viral load of the patient. The medicine may not help cure HIV, but it opens further new avenues for future research,” Shah told The Indian Express.
In 25.9 per cent patients, the viral load declined from 12 to 24 weeks of receiving the homoeopathic medicine. Shah said the clinical trials included patients who had CD-4 count above 350 to eliminate any risk. “We also did not incorporate any patient who may have other co-morbid conditions so that we could solely focus on the virus,” he said.
The homoeopathic medicine was created was in ‘extreme diluted form’. The virus was isolated, processed and was formed using a process of ‘potentisation’, a procedure used negate the toxic effects from crude drugs.
Speaking on the research, Shah said, “This is the first time, the HIV has been isolated to treat the disease it causes. After isolating the virus, we processed it through potentisation. Small doses were given to each patient.”
The research publish comes days before the Global Homeopathic Foundation meet scheduled in Mumbai from April 11. Around 25 scientists and homeopathic doctors from across the globe, including Shah, are scheduled to discuss their research in the field of homoeopathy.
Previously, the Central Council for Research in Homoeopathy, India, also conducted a clinical trial from 1989 to 2005 of 870 participants to check how homoeopathic medicines had shown positive effect in managing people with HIV infection.
Dr Kanjaksha Ghosh, former director of Indian Council of Medical Research, said, “We cannot solely depend on homoeopathy to treat certain diseases. But increased research is indicating that homoeopathy can be used along with other medicines to treat infections such as tuberculosis and HIV. It has a wide scope and must be applied more.”